No clear results were found that any of the identified genetic variants in BRIP1, RAD50, or CDH1 would increase the BrCa/OvCa risk in the analyzed high-risk Finnish HBOC individuals. The gene discussed is RAD50; the disease is invasive breast carcinoma.